Article

InSite obtains rights to optineurin gene

A test for the optineurin gene will be available to ophthalmologists soon - possibly this year and certainly by 2003, said S. Kumar Chandrasekaran, PhD, CEO of InSite Vision, Alameda, CA.

Related Videos
AAO 2024: Matt Giegengack, MD: Injectable endothelial cell therapy shows promise for improving vision and reducing glare in corneal edema
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Related Content
Understanding cerebral/cortical visual impairment: New insights and advances in diagnosis
November 22nd 2024

Understanding cerebral/cortical visual impairment: New insights and advances in diagnosis

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Prevent Blindness declares 5th annual Thyroid Eye Disease Awareness Week
November 15th 2024

Prevent Blindness declares 5th annual Thyroid Eye Disease Awareness Week

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Noninvasive choroidal vessel analysis using deep learning: A novel approach to OCT angiography
November 11th 2024

Noninvasive choroidal vessel analysis using deep learning: A novel approach to OCT angiography

Prevent Blindness recognizes November as Diabetes-Related Eye Disease Awareness Month
November 5th 2024

Prevent Blindness recognizes November as Diabetes-Related Eye Disease Awareness Month

© 2024 MJH Life Sciences

All rights reserved.